61 related articles for article (PubMed ID: 10800181)
1. CD79b expression in B-cell chronic lymphocytic leukemia.
D'Arena G; Cascavilla N; Musto P; Colella Bisogno R; Pistolese G; Carotenuto M
Haematologica; 2000 May; 85(5):556-7. PubMed ID: 10800181
[No Abstract] [Full Text] [Related]
2. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
4. Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemia.
Finolezzi E; Corral L; Martelli MP; De Propris MS; Falini B; Cimino G
Haematologica; 2002 Oct; 87(10):ELT41. PubMed ID: 12368180
[No Abstract] [Full Text] [Related]
5. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
[TBL] [Abstract][Full Text] [Related]
6. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes.
Porakishvili N; Kulikova N; Jewell AP; Youinou PY; Yong K; Nathwani A; Heelan B; Duke V; Hamblin TJ; Wallace P; Ely P; Clark EA; Lydyard PM
Br J Haematol; 2005 Nov; 131(3):313-9. PubMed ID: 16225650
[TBL] [Abstract][Full Text] [Related]
8. High resolution immunophenotypic analysis of chronic lymphocytic leukemic cells by enzymatic amplification staining.
Kaplan D; Meyerson H; Lewandowska K
Am J Clin Pathol; 2001 Sep; 116(3):429-36. PubMed ID: 11554172
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.
Cruse JM; Lewis RE; Pierce S; Lam J; Tadros Y
Exp Mol Pathol; 2005 Aug; 79(1):39-41. PubMed ID: 16005710
[TBL] [Abstract][Full Text] [Related]
10. Lack of HLA-DR expression in a patient with B-chronic lymphocytic leukemia.
Vartholomatos G; Kapsali E; Dokou E; Bourantas KL
J Exp Clin Cancer Res; 2001 Jun; 20(2):305-6. PubMed ID: 11484993
[TBL] [Abstract][Full Text] [Related]
11. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
12. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
13. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
[TBL] [Abstract][Full Text] [Related]
14. Bimodal cell populations are common in chronic lymphocytic leukemia but do not impact overall survival.
Cocco AE; Osei ES; Thut DM; Edinger AK; Powers JJ; Fu P; Meyerson HJ
Am J Clin Pathol; 2005 Jun; 123(6):818-25. PubMed ID: 15899771
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
[TBL] [Abstract][Full Text] [Related]
16. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of CD79a (Ig alpha) and CD79b (Ig beta) transcripts in human B-CLL cells.
Alfarano A; Circosta P; Vallario A; Camaschella C; Indraccolo S; Amadori A; Caligaris-Cappio F
Curr Top Microbiol Immunol; 1999; 246():241-6; discussion 247-8. PubMed ID: 10396062
[No Abstract] [Full Text] [Related]
18. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome?
Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
Haematologica; 2003 Mar; 88(3):354-5. PubMed ID: 12651280
[No Abstract] [Full Text] [Related]
19. CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Leukemia; 2005 Jun; 19(6):1099-101. PubMed ID: 15830006
[No Abstract] [Full Text] [Related]
20. B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle.
Bennett F; Rawstron A; Plummer M; de Tute R; Moreton P; Jack A; Hillmen P
Br J Haematol; 2007 Nov; 139(4):600-4. PubMed ID: 17979945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
